15-hydroxy-5,8,11,13,17-eicosapentaenoic acid has been researched along with 15-keto-5,8,11,13-eicosatetraenoic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J; Lian, M; Shen, T; Shi, H; Wei, L; Xing, Y; Yu, X; Zhang, B; Zhu, D | 1 |
1 other study(ies) available for 15-hydroxy-5,8,11,13,17-eicosapentaenoic acid and 15-keto-5,8,11,13-eicosatetraenoic acid
| Article | Year |
|---|---|
15-PGDH/15-KETE plays a role in hypoxia-induced pulmonary vascular remodeling through ERK1/2-dependent PAR-2 pathway.
Topics: Animals; Arachidonic Acids; Cell Cycle; Cell Cycle Proteins; Cell Hypoxia; Cell Proliferation; Cells, Cultured; Eicosapentaenoic Acid; Extracellular Signal-Regulated MAP Kinases; Humans; Hydroxyprostaglandin Dehydrogenases; Hypertension, Pulmonary; Lung; Male; MAP Kinase Signaling System; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Pulmonary Artery; Random Allocation; Rats; Rats, Wistar; Receptor, PAR-2; RNA Interference; RNA, Small Interfering; Vascular Remodeling | 2014 |